SCHEMBL15280830

SCHEMBL15280830

Cc1cn([C@@H]2O[C@@]3(CC(C)(C)C)CO[C@H]2C3OC(C)(C)C)c(=O)nc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22060532 1.00
SCHEMBL19887044 1.00
SCHEMBL19522867 0.90
SCHEMBL19887021 0.90
SCHEMBL15280825 0.90
SCHEMBL24699871 0.89
SCHEMBL26044333 0.86
SCHEMBL22021318 0.86
SCHEMBL22060531 0.86
SCHEMBL15280879 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018516-A1 Agent for Regulating Expression and/or Function of RPS25 Gene Sumitomo Pharma Co., Ltd. (JP) 2024-01-18 US disclosed
US-9803199-B2 Cationic lipid DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-10-31 US disclosed
US-20160257951-A1 NOVEL LIPID DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-09-08 US disclosed
US-8987226-B2 Modified single-stranded polynucleotides DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-03-24 US disclosed
US-20130253038-A1 Modified Single-Stranded Polynucleotide DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-09-26 US disclosed